Menu

Blog

Archive for the ‘genetics’ category: Page 246

May 5, 2020

Epidemiologists develop new tool for measuring the pace of aging across the life course

Posted by in categories: biotech/medical, genetics, life extension, neuroscience

A study just released by Columbia University Mailman School of Public Health is reporting a blood-DNA-methylation measure that is sensitive to variation in the pace of biological aging among individuals born the same year. The tool—DunedinPoAm—offers a unique measurement for intervention trials and natural experiment studies investigating how the rate of aging may be changed by behavioral or drug therapy, or by changes to the environment. The study findings are published online in the journal eLife.

“The goal of our study was to distill a measurement of the rate of biological aging based on 12-years of follow-up on 18 different clinical tests into a blood test that can be administered at a single time point.” said lead author Daniel Belsky, Ph.D., assistant professor of epidemiology at Columbia Mailman School and a researcher at the Columbia Aging Center.

Midlife adults measured to be aging faster according to the new measurement showed faster declines in physical and cognitive functioning and looked older in facial photographs. Older adults measured to be aging faster by the tool were at increased risk for chronic disease and mortality. In other analyses, the researchers showed that DunedinPoAm captured new information not measured by proposed measures of biological aging known as epigenetic clocks, that 18-year-olds with histories of childhood poverty and victimization showed faster aging as measured by DunedinPoAm, and that DunedinPoAm predictions were disrupted by a caloric restriction intervention in a randomized trial.

May 4, 2020

ASU scientific team finds new, unique mutation in coronavirus study

Posted by in categories: biotech/medical, chemistry, genetics

To trace the trail of the virus worldwide, Lim’s team is using a new technology called next-generation sequencing at ASU’s Genomics Facility, to rapidly read through all 30,000 chemical letters of the SARS-CoV-2 genetic code, called a genome.

Each sequence is deposited into a worldwide gene bank, run by a nonprofit scientific organization called GISAID. To date, over 16,000 SARS-CoV-2 sequences have been deposited GISAID’s EpiCoVTM Database. The sequence data shows that SARS-CoV-2 originated a single source from Wuhan, China, while many of the first Arizona cases analyzed showed travel from Europe as the most likely source.

Now, using a pool of 382 nasal swab samples obtained from possible COVID-19 cases in Arizona, Lim’s team has identified a SARS-CoV-2 mutation that had never been found before—where 81 of the letters have vanished, permanently deleted from the genome.

May 4, 2020

‘Unnecessary’ genetic complexity: A spanner in the works?

Posted by in categories: biotech/medical, genetics, health

The breakthrough, which identified the location and function of every human gene, offered the promise of medical care tailored specifically to individual patients, based on their personal genetic makeup.

When researchers identified a gene associated with a 44 per cent risk of breast cancer in women, for example, it seemed that protecting them might be as simple as deactivating that gene.

But the promise of such personalized medicine has not fully materialized, say two McMaster researchers, because the full sophistication of the genetic blueprint has a more complex and far-reaching influence on human health than scientists had first realized.

May 4, 2020

Antibody prevents the COVID-19 virus from infecting human cells

Posted by in categories: biotech/medical, genetics, health

Antibody found to block infection by the novel coronavirus SARS-CoV-2 in cells.

The ‘47D11’ antibody targets the ‘spike protein’ of the destructive coronavirus.

Continue reading “Antibody prevents the COVID-19 virus from infecting human cells” »

May 3, 2020

Pompeo: ‘Enormous Evidence’ Links Virus to China Lab

Posted by in categories: biotech/medical, genetics

U.S. Secretary of State Michael Pompeo said “enormous evidence” shows the novel coronavirus outbreak began in a laboratory in Wuhan, China, but didn’t provide any proof for his claims.

“I can tell you that there is a significant amount of evidence that this came from that laboratory in Wuhan,” Pompeo said on ABC’s “This Week.” “These are not the first times that we’ve had a world exposed to viruses as a result of failures in a Chinese lab.”

Pompeo stopped short of saying the virus was man-made, noting that he agreed with a report by the Office of the Director of National Intelligence that ruled out genetic modification or it having been man-made.

May 3, 2020

Can Genetic Engineering Bring Back the American Chestnut?

Posted by in categories: bioengineering, biotech/medical, genetics

The tree helped build industrial America before disease wiped out an estimated three billion or more of them. To revive their lost glory, we may need to embrace tinkering with nature.

An American chestnut near Rockport, Maine. Credit… John Chiara for The New York Times.

May 3, 2020

Help NYC artist Maria Alekseev

Posted by in categories: biotech/medical, employment, finance, food, genetics, health, neuroscience

Maria became the very first COVID-19 patient to use Stem Cell Neurotherapy for COVID-19. In about 5 days, she will began to feel the healing effects of generating new lung cells which will eliminate her breathing problems.

We repurposed some tools from the Stem Cell Therapy for Cancer/Brain Tumor. Those tools are T-Cells, B-Cells, and Natural Killer Cells. Instead of programming those cancer killing cells to attack cancer cells, we have programmed them to seek out, identify, attack, and destroy all the Coronavirus cells in the entire body.

Stem Cell Neurotherapy sends therapeutic messages, e.g., “your stem cells are transforming into new cells for the lungs, liver, and kidneys” to the DNA inside the nucleus of stem cells. Inside the nucleus, the DNA receives the message and transmits it to the RNA, which translates the message into genetic code.

Continue reading “Help NYC artist Maria Alekseev” »

May 2, 2020

US invests hundreds of millions to produce Covid-19 vaccines

Posted by in categories: biotech/medical, genetics

Jordan says Moderna is able to scale up quicker than traditional manufacturers, as its vaccines are created by manipulating mRNA, the molecule that carries genetic instructions from DNA to a cell’s protein-making ribosome. Moderna manipulates mRNA so that it instructs human cells to produce certain viral proteins; the proteins themselves don’t cause infection, but they do invoke an immune response. “The RNA uses the human body as its bioreactor,” says Jordan, so Moderna itself doesn’t have to manufacture the proteins. “To create a different vaccine candidate [for Moderna] is to trigger a different RNA sequence. We don’t need to build a different cell processing plant,” says Jordan.

The central dogma of molecular biology deals with the detailed residue-by-residue transfer of sequential information. It states that such information cannot be transferred back from protein to either protein or nucleic acid.— Francis Crick.

The dogma is a framework for understanding the transfer of sequence information between information-carrying biopolymers, in the most common or general case, in living organisms. There are 3 major classes of such biopolymers: DNA and RNA (both nucleic acids), and protein. There are 3×3=9 conceivable direct transfers of information that can occur between these. The dogma classes these into 3 groups of 3: three general transfers (believed to occur normally in most cells), three special transfers (known to occur, but only under specific conditions in case of some viruses or in a laboratory), and three unknown transfers (believed never to occur). The general transfers describe the normal flow of biological information: DNA can be copied to DNA (DNA replication), DNA information can be copied into mRNA (transcription), and proteins can be synthesized using the information in mRNA as a template (translation). The special transfers describe: RNA being copied from RNA (RNA replication), DNA being synthesised using an RNA template (reverse transcription), and proteins being synthesised directly from a DNA template without the use of mRNA. The unknown transfers describe: a protein being copied from a protein, synthesis of RNA using the primary structure of a protein as a template, and DNA synthesis using the primary structure of a protein as a template — these are not thought to naturally occur. [6].

Continue reading “US invests hundreds of millions to produce Covid-19 vaccines” »

May 2, 2020

From DNA to protein — 3D

Posted by in categories: biotech/medical, genetics, neuroscience

We can reprogram our DNA. The nucleus of a cell is not read only. It is actually read and write. Basically, the cell is a programmable device, in response to environmental information.

The templates for protein synthesis are RNA (ribonucleic acid) molecules. In particular, a class of RNA molecules called messenger RNA (mRNA) are the information-carrying intermediates in protein synthesis. Other RNA molecules, such as transfer RNA (tRNA) and ribosomal RNA (rRNA), are part of the protein-synthesizing machinery. All forms of cellular RNA are synthesized by RNA polymerases that take instructions from DNA templates. This process of transcription is followed by translation, the synthesis of proteins according to instructions given by mRNA templates.

Continue reading “From DNA to protein — 3D” »

May 2, 2020

Genetic Engineering Could Make a COVID-19 Vaccine in Months Rather Than Years

Posted by in categories: bioengineering, biotech/medical, genetics

Candidates are speeding toward human trials.